SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting
Stockholder Approval Represents Key Milestone Toward Completion of Standard BioTools Transaction
Combination Will Create a Diversified Leader in Life Sciences Tools
Related news for (SLGC)
- Madryn Asset Management Addresses SomaLogic’s Apparent Failure to Obtain Requisite Shareholder Support for the Proposed Merger with Standard BioTools
- Proxy Advisory Firm Egan-Jones Recommends SomaLogic Shareholders Vote Against Proposed Merger with Standard BioTools
- SomaLogic Urges Stockholders to Maximize Value of Their Investment by Voting “FOR” Pending Merger with Standard BioTools
- Madryn Asset Management Highlights Increasing Public Shareholder Opposition to Value-Destructive SomaLogic Merger and Calls on Company to Make Additional Disclosures